Get startedLog in
    Picture of Exagen logo

    XGN — Exagen News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Exagen Initiates Study To Predict Rheumatoid Arthritis Drug Response (Radr) In Patients With Ra

    Picture of Exagen logoExagen
    04/08/2022 22:57
    Aug 4 (Reuters) - Exagen Inc  XGN.O :
    * EXAGEN INITIATES STUDY TO PREDICT RHEUMATOID ARTHRITIS
DRUG
RESPONSE (RADR) IN PATIENTS WITH RA

Source text for Eikon:  ID:nGNX5gkGbd 
Further company coverage:  XGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Exagen

    See all news